Cerebral distribution of beta-lipotropin and beta-endorphin in infantile progressive spinal muscular atrophy of Werdnig and Hoffman disease. 1987

A Pasi, and P Mehraein, and E Pedrinis, and H Hartmann, and C Gramsch, and P Külling, and F Pagnamenta, and F S Messiha

The regional distribution's profile of beta-endorphin (beta-EP) and beta-lipotropin (beta-LPH) was determined in the brain of an infant who died from Werdnig-Hoffmann's disease. Regional levels of beta-endorphin-like immunoreactivity (beta-ELIR), resulting from beta-EP and beta-LPH, were generally low in comparison to the homologous levels found in victims dying of other diseases.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008083 beta-Lipotropin A 90-amino acid peptide derived from post-translational processing of pro-opiomelanocortin (POMC) in the PITUITARY GLAND and the HYPOTHALAMUS. It is the C-terminal fragment of POMC with lipid-mobilizing activities, such as LIPOLYSIS and steroidogenesis. Depending on the species and the tissue sites, beta-LPH may be further processed to yield active peptides including GAMMA-LIPOTROPIN; BETA-MSH; and ENDORPHINS. Lipotropin,Adipozin,beta-LPH,beta-Lipotrophin,beta LPH,beta Lipotrophin,beta Lipotropin
D009133 Muscular Atrophy Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation. Atrophy, Muscle,Neurogenic Muscular Atrophy,Neurotrophic Muscular Atrophy,Atrophies, Muscle,Atrophies, Muscular,Atrophies, Neurogenic Muscular,Atrophies, Neurotrophic Muscular,Atrophy, Muscular,Atrophy, Neurogenic Muscular,Atrophy, Neurotrophic Muscular,Muscle Atrophies,Muscle Atrophy,Muscular Atrophies,Muscular Atrophies, Neurogenic,Muscular Atrophies, Neurotrophic,Muscular Atrophy, Neurogenic,Muscular Atrophy, Neurotrophic,Neurogenic Muscular Atrophies,Neurotrophic Muscular Atrophies
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D004723 Endorphins One of the three major groups of endogenous opioid peptides. They are large peptides derived from the PRO-OPIOMELANOCORTIN precursor. The known members of this group are alpha-, beta-, and gamma-endorphin. The term endorphin is also sometimes used to refer to all opioid peptides, but the narrower sense is used here; OPIOID PEPTIDES is used for the broader group. Endorphin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001615 beta-Endorphin A 31-amino acid peptide that is the C-terminal fragment of BETA-LIPOTROPIN. It acts on OPIOID RECEPTORS and is an analgesic. Its first four amino acids at the N-terminal are identical to the tetrapeptide sequence of METHIONINE ENKEPHALIN and LEUCINE ENKEPHALIN. Endorphin, beta,beta-Endorphin (1-31),beta Endorphin

Related Publications

A Pasi, and P Mehraein, and E Pedrinis, and H Hartmann, and C Gramsch, and P Külling, and F Pagnamenta, and F S Messiha
August 1971, Die Medizinische Welt,
A Pasi, and P Mehraein, and E Pedrinis, and H Hartmann, and C Gramsch, and P Külling, and F Pagnamenta, and F S Messiha
January 1958, Zeitschrift fur Kinderheilkunde,
A Pasi, and P Mehraein, and E Pedrinis, and H Hartmann, and C Gramsch, and P Külling, and F Pagnamenta, and F S Messiha
July 1984, Boletin medico del Hospital Infantil de Mexico,
A Pasi, and P Mehraein, and E Pedrinis, and H Hartmann, and C Gramsch, and P Külling, and F Pagnamenta, and F S Messiha
February 1954, Acta neurologica et psychiatrica Belgica,
A Pasi, and P Mehraein, and E Pedrinis, and H Hartmann, and C Gramsch, and P Külling, and F Pagnamenta, and F S Messiha
November 1962, Polski tygodnik lekarski (Warsaw, Poland : 1960),
A Pasi, and P Mehraein, and E Pedrinis, and H Hartmann, and C Gramsch, and P Külling, and F Pagnamenta, and F S Messiha
June 1957, Revista cubana de pediatria,
A Pasi, and P Mehraein, and E Pedrinis, and H Hartmann, and C Gramsch, and P Külling, and F Pagnamenta, and F S Messiha
January 1975, ASDC journal of dentistry for children,
A Pasi, and P Mehraein, and E Pedrinis, and H Hartmann, and C Gramsch, and P Külling, and F Pagnamenta, and F S Messiha
June 1973, Archives of disease in childhood,
A Pasi, and P Mehraein, and E Pedrinis, and H Hartmann, and C Gramsch, and P Külling, and F Pagnamenta, and F S Messiha
October 1973, Archives of disease in childhood,
A Pasi, and P Mehraein, and E Pedrinis, and H Hartmann, and C Gramsch, and P Külling, and F Pagnamenta, and F S Messiha
January 1968, Folia hereditaria et pathologica,
Copied contents to your clipboard!